FOXP2 and colorectal carcinoma: Moreover, FOXP2 had oncogenic roles in CRC and miR-9-5p could inhibit cell metastasis and EMT in CRC by targeting FOXP2. The low miR-9-5p levels and the high FOXP2 levels were associated with poor prognosis of CRC patients.